PTPN3 acts as a tumor suppressor and boosts TGF-β signaling independent of its phosphatase activity

Bo Yuan1, Jinquan Liu1, Jin Cao1

  • 1The MOE Key Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang, China.

The EMBO Journal
|July 16, 2019
PubMed

Insights

Protein tyrosine phosphatase non-receptor 3 (PTPN3) enhances transforming growth factor-beta (TGF-β) signaling by stabilizing the TGF-β type I receptor. Mutations in PTPN3 are linked to cancer, highlighting its role in disease.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-β) signaling is crucial for development and its dysregulation is implicated in diseases like cancer.
  • Tight regulation of TGF-β signaling pathways is essential for maintaining cellular homeostasis and preventing pathogenesis.

Purpose of the Study:

  • To investigate the role of protein tyrosine phosphatase non-receptor 3 (PTPN3) in regulating TGF-β signaling.
  • To elucidate the mechanism by which PTPN3 influences TGF-β pathway activity.
  • To examine the impact of PTPN3 mutations on TGF-β signaling and tumor suppression.

Main Methods:

  • Biochemical assays to assess PTPN3's phosphatase activity and its effect on TGF-β signaling components.
  • Co-immunoprecipitation to analyze the interaction between PTPN3, Smurf2, and the TGF-β type I receptor (TβRI).
  • Analysis of TGF-β-induced R-Smad phosphorylation and downstream transcriptional responses.
  • Investigation of the functional consequences of a specific PTPN3 mutation (L232R) found in intrahepatic cholangiocarcinoma (ICC).

Main Results:

  • PTPN3 potentiates TGF-β signaling independently of its phosphatase activity.
  • PTPN3 stabilizes TβRI by preventing its interaction with Smurf2.
  • PTPN3 enhances TGF-β-induced R-Smad phosphorylation and downstream cellular responses.
  • The PTPN3 L232R mutation abrogates its ability to enhance TGF-β signaling and impairs its tumor-suppressive function in ICC.

Conclusions:

  • PTPN3 plays a critical role in potentiating TGF-β signaling through TβRI stabilization.
  • PTPN3 acts as a key regulator of TGF-β pathway activity in both normal physiology and disease.
  • The PTPN3 L232R mutation represents a mechanism by which aberrant TGF-β signaling contributes to ICC development.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.0K
Introduction to Test of Independence01:21

Introduction to Test of Independence

In statistics, the term independence means that one can directly obtain the probability of any event involving both variables by multiplying their individual probabilities. Tests of independence are chi-square tests involving the use of a contingency table of observed (data) values.
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
2.9K